hydrogen has been researched along with Cerebral Infarction in 11 studies
Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.
dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to test the hypothesis that the efficacy of 7-nitroindazole (7-NI), a selective neuronal nitric oxide (NO) synthase (NOS) inhibitor, is pH dependent in vivo during focal cerebral ischemia." | 3.72 | Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH? ( Anderson, RE; Coert, BA; Meyer, FB, 2003) |
| " First, in patients with cerebral infarctions, increased concentrations of lactate were found in the majority of patients, and N-acetyl aspartate (NAA) was reduced to a significantly greater extent than choline (Cho) or creatine (Cre)." | 3.68 | Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. ( Calabrese, G; Deicken, R; Fein, G; Fisher, SN; Hetherington, HP; Sappey-Marinier, D; Van Dyke, C; Weiner, MW, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, H | 1 |
| Nishijima, Y | 1 |
| Ohta, S | 3 |
| Sakamoto, M | 1 |
| Kinone, K | 1 |
| Horikosi, T | 1 |
| Tamaki, M | 1 |
| Takeshita, H | 1 |
| Futatuki, T | 1 |
| Ohishi, W | 1 |
| Ishiguro, T | 1 |
| Okamoto, S | 1 |
| Ishii, S | 1 |
| Takanami, H | 1 |
| Anderson, RE | 2 |
| Meyer, FB | 2 |
| Coert, BA | 1 |
| Ohsawa, I | 1 |
| Ishikawa, M | 1 |
| Takahashi, K | 1 |
| Watanabe, M | 1 |
| Nishimaki, K | 1 |
| Yamagata, K | 1 |
| Katsura, K | 1 |
| Katayama, Y | 2 |
| Asoh, S | 1 |
| Yamamuro, M | 1 |
| Igarashi, H | 1 |
| Terashi, A | 1 |
| Sick, TJ | 1 |
| Tang, R | 1 |
| Pérez-Pinzón, MA | 1 |
| Wang, Z | 1 |
| Bogdan, AR | 1 |
| Zimmerman, RA | 1 |
| Gusnard, DA | 1 |
| Leigh, JS | 1 |
| Ohene-Frempong, K | 1 |
| Hugg, JW | 1 |
| Duijn, JH | 1 |
| Matson, GB | 1 |
| Maudsley, AA | 1 |
| Tsuruda, JS | 1 |
| Gelinas, DF | 1 |
| Weiner, MW | 2 |
| Sappey-Marinier, D | 1 |
| Calabrese, G | 1 |
| Hetherington, HP | 1 |
| Fisher, SN | 1 |
| Deicken, R | 1 |
| Van Dyke, C | 1 |
| Fein, G | 1 |
| Houkin, K | 1 |
| Matsuzawa, H | 1 |
| Miyasaka, K | 1 |
| Kamiyama, H | 1 |
| Iwasaki, Y | 1 |
| Abe, H | 1 |
| Hida, K | 1 |
| Koiwa, M | 1 |
| Kashiwaba, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines[NCT05476575] | 32 participants (Anticipated) | Interventional | 2021-10-28 | Recruiting | |||
| Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis (HYBRID): A Randomized, Multi-center, Double-blind, Parallel-group Study[NCT02765295] | 120 participants (Anticipated) | Interventional | 2016-06-01 | Recruiting | |||
| Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study[NCT04716985] | 700 participants (Actual) | Interventional | 2021-01-22 | Active, not recruiting | |||
| Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study[NCT02850185] | 170 participants (Anticipated) | Interventional | 2016-07-15 | Recruiting | |||
| Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study on Effectiveness and Safety[NCT02883582] | 150 participants (Anticipated) | Interventional | 2016-08-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydrogen and Cerebral Infarction
| Article | Year |
|---|---|
[Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept].
Topics: Animals; Antioxidants; Cells, Cultured; Cerebral Infarction; Gases; Hydrogen; Rats; Water | 2008 |
1 trial available for hydrogen and Cerebral Infarction
| Article | Year |
|---|---|
Hydrogen Gas Inhalation Treatment in Acute Cerebral Infarction: A Randomized Controlled Clinical Study on Safety and Neuroprotection.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Blood Pressure; Cerebral Infarction; Diffusion | 2017 |
9 other studies available for hydrogen and Cerebral Infarction
| Article | Year |
|---|---|
Protection of focal cerebral ischemia by alkalinization of systemic pH.
Topics: Alkalies; Animals; Brain; Brain Ischemia; Carbonates; Cerebral Cortex; Cerebral Infarction; Cerebrov | 2002 |
Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH?
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Enzyme Inhibitors; | 2003 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
Topics: Administration, Inhalation; Animals; Antioxidants; Cerebral Infarction; Disease Models, Animal; Huma | 2007 |
[1H and 31P-magnetic resonance spectroscopy of cerebral infarction in rats].
Topics: Animals; Brain; Brain Chemistry; Cerebral Infarction; Hydrogen; Magnetic Resonance Spectroscopy; Mal | 1997 |
Cerebral blood flow does not mediate the effect of brain temperature on recovery of extracellular potassium ion activity after transient focal ischemia in the rat.
Topics: Animals; Body Temperature; Brain; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular | 1999 |
Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Aspartic Acid; Atrophy; Brain; Brain Ischemia; Cerebral Infa | 1992 |
Elevated lactate and alkalosis in chronic human brain infarction observed by 1H and 31P MR spectroscopic imaging.
Topics: Adult; Aged; Aged, 80 and over; Alkalosis; Cerebral Infarction; Female; Humans; Hydrogen; Lactates; | 1992 |
Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Chemistry; Brain Ischemia; Cerebral Infarction; | 1992 |
[Longitudinal change of H-1 spectroscopy in cerebral infarction].
Topics: Aged; Aspartic Acid; Brain; Cerebral Infarction; Female; Humans; Hydrogen; Lactates; Lactic Acid; Ma | 1991 |